Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin-Doxycycline Rescue Therapy for H. pylori
NCT02884713Completed
- Sponsor
- King Faisal Specialist Hospital and Research Centre
- Start
- Jun 2013
- Primary completion
- Apr 2014
- Modality
- Small Molecules
01
Overview
Open-label, single-arm trial of levofloxacin and doxycycline in Helicobacter pylori infection, sponsored by King Faisal Specialist Hospital and Research Centre. Primary endpoint: Eradication rate of H. pylori at 6 weeks. Started Jun 2013; status: completed.
02
Drugs
levofloxacindoxycycline
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT02884713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02884713.